Beth A. Taylor
CIK 1522046 · Chief Financial Officer · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
36
Lifetime Open-Market Net
$12.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Inotiv, Inc. (NOTV) Delisted | Chief Financial Officer | 0 | $0.08 | $0 | $137.7K | 17 | 2026-07-20 |
| Inotiv, Inc. (BASI) Delisted | VP- Finance & CFO | 34,295 | $16.44 | $563.8K | $147.4K | 4 | 2021-03-05 |
| ENDOCYTE INC (ECYT) Delisted | VP Finance & Chief Acctg Off | 0 | — | — | -$272.3K | 15 | 2018-12-21 |
Recent Filings · Page 3 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-21 | Inotiv, Inc. (BASI) Delisted | Buy (P) | +13,300 | $58.9K | EDGAR |
| 2018-12-21 | ENDOCYTE INC (ECYT) Delisted | Disp (D) | −99,509 | -$2.39M | EDGAR |
| 2018-12-19 | ENDOCYTE INC (ECYT) Delisted | Mixed | +43,168 | $210.5K | EDGAR |
| 2018-10-09 | ENDOCYTE INC (ECYT) Delisted | Sell (S) | −7,022 | -$109.3K | EDGAR |
| 2018-08-29 | ENDOCYTE INC (ECYT) Delisted | Sell (S) | −7,892 | -$157.8K | EDGAR |
| 2018-08-22 | ENDOCYTE INC (ECYT) Delisted | Sell (S) | −285 | -$5.2K | EDGAR |
| 2018-02-08 | ENDOCYTE INC (ECYT) Delisted | Mixed | +12,016 | -$1.5K | EDGAR |
| 2018-02-06 | ENDOCYTE INC (ECYT) Delisted | Tax (F) | −1,759 | -$5.5K | EDGAR |
| 2017-10-06 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2017-02-03 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.